InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 509.50
+3.30 (0.65%)
Jul 21, 2025, 11:59 AM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 238.74 million as of July 21, 2025. Its market cap has decreased by -31.29% in one year.
Market Cap
238.74M
Enterprise Value
372.19M
Revenue
238.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
509.50
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.41M to 238.74M, an increase of 3,625.20%. That is a compound annual growth rate of 28.11%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 61.84B |
| Danel (Adir Yeoshua) | 2.87B |
| Kamada | 1.49B |
| Bait Bakfar | 1.06B |
| SofWave Medical | 851.06M |
| BrainsWay | 771.39M |
| Novolog (Pharm-Up 1966) | 716.71M |
| Ilex Medical | 671.06M |